NVOon logo

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The...

NYSEHealthcareDrug Manufacturers - GeneralUSA

公司簡介

股票程式碼
NVO
ISIN程式碼
US6701002056
貨幣
US Dollar (USD)
IPO日期
1982-01-04

聯絡資訊

公司地址
Novo Alle 1, Bagsvaerd, Denmark, 2880
聯絡電話
45 44 44 88 88
公司網站
https://www.novonordisk.com
財年結束
December

財務亮點

市值
$999,999.99
毛利潤(TTM)
$999,999.99
股息收益率
4.06%
資產回報率(TTM)
19.25%
EBITDA
$999,999.99
收入(TTM)
$999,999.99